Influence of Virulence Genotype and Resistance Profile in the Mortality of Pseudomonas aeruginosa Bloodstream Infections

Epidemiology and carbapenem resistance mechanisms of carbapenem-non-susceptible Pseudomonas aeruginosa collected during 2009-11 in 14 European and Mediterranean countries

(2014) M. Castanheira et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Prevalence of Type III Secretion Protein Exoenzymes and Antimicrobial Susceptibility Patterns from Bloodstream Isolates of Patients withPseudomonas aeruginosaBacteremia

(2014) K.W. Garey et al.   JOURNAL OF CHEMOTHERAPY

Biological Markers of Pseudomonas aeruginosa Epidemic High-Risk Clones

(2013) Xavier Mulet et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Bacterial and Clinical Characteristics of Health Care- and Community-Acquired Bloodstream Infections Due to Pseudomonas aeruginosa

(2013) Angela Hattemer et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Effect of Adequate Single-Drug vs Combination Antimicrobial Therapy on Mortality in Pseudomonas aeruginosa Bloodstream Infections: A Post Hoc Analysis of a Prospective Cohort

(2013) Carmen Peña et al.   CLINICAL INFECTIOUS DISEASES

Antimicrobial Resistance and Virulence: a Successful or Deleterious Association in the Bacterial World?

(2013) A. Beceiro et al.   CLINICAL MICROBIOLOGY REVIEWS

Risk of Developing Pneumonia Is Enhanced by the Combined Traits of Fluoroquinolone Resistance and Type III Secretion Virulence in Respiratory Isolates of Pseudomonas aeruginosa*

(2013) Eva Sullivan et al.   CRITICAL CARE MEDICINE

Impact of multidrug resistance on Pseudomonas aeruginosa ventilator-associated pneumonia outcome: predictors of early and crude mortality

(2013) C. Peña et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Dissemination of metallo- -lactamase-producing Pseudomonas aeruginosa of sequence type 235 in Asian countries

(2013) M. J. Kim et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Spread of extensively resistant VIM-2-positive ST235 Pseudomonas aeruginosa in Belarus, Kazakhstan, and Russia: a longitudinal epidemiological and clinical study

(2013) Mikhail V Edelstein et al.   LANCET INFECTIOUS DISEASES

Genetic Markers of Widespread Extensively Drug-Resistant Pseudomonas aeruginosa High-Risk Clones

(2012) Gabriel Cabot et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical populations of Pseudomonas aeruginosa isolated from acute infections show a wide virulence range partially correlated with population structure and virulence gene expression

(2012) H. A. Janjua et al.   MICROBIOLOGY-SGM

Differentiation in Quinolone Resistance by Virulence Genotype in Pseudomonas aeruginosa

(2012) Melissa Agnello et al.   PLoS One

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

(2011) A.-P. Magiorakos et al.   CLINICAL MICROBIOLOGY AND INFECTION

Clinical outcomes of type III Pseudomonas aeruginosa bacteremia*

(2011) Ali A. El-Solh et al.   CRITICAL CARE MEDICINE

Most Multidrug-Resistant Pseudomonas aeruginosa Isolates from Hospitals in Eastern France Belong to a Few Clonal Types

(2011) Pascal Cholley et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Population Structure of Pseudomonas aeruginosa from Five Mediterranean Countries: Evidence for Frequent Recombination and Epidemic Occurrence of CC235

(2011) Makaoui Maatallah et al.   PLoS One

Nosocomial Spread of Colistin-Only-Sensitive Sequence Type 235 Pseudomonas aeruginosa Isolates Producing the Extended-Spectrum  -Lactamases GES-1 and GES-5 in Spain

(2009) E. Viedma et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pseudomonas aeruginosa virulence and therapy: Evolving translational strategies*

(2009) Jeffrey L. Veesenmeyer et al.   CRITICAL CARE MEDICINE

Role of Pseudomonas aeruginosa type III effectors in disease

(2009) Joanne Engel et al.   CURRENT OPINION IN MICROBIOLOGY

The type III secretion system of Pseudomonas aeruginosa: infection by injection

(2009) Alan R. Hauser   NATURE REVIEWS MICROBIOLOGY

Comparison of type III secretion system virulence among fluoroquinolone-susceptible and -resistant clinical isolates of Pseudomonas aeruginosa

(2008) A. Wong-Beringer et al.   CLINICAL MICROBIOLOGY AND INFECTION